Remed Co (XKRX:302550) Short-Term Capital Lease Obligation : ₩152 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Remed Co Short-Term Capital Lease Obligation?

Remed Co's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩152 Mil.

Remed Co's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (₩65 Mil) to Dec. 2023 (₩149 Mil) and increased from Dec. 2023 (₩149 Mil) to Mar. 2024 (₩152 Mil).

Remed Co's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (₩52 Mil) to Dec. 2022 (₩59 Mil) and increased from Dec. 2022 (₩59 Mil) to Dec. 2023 (₩149 Mil).

Remed Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for Remed Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remed Co Short-Term Capital Lease Obligation Chart

Remed Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

73.21

96.67

51.92

58.71

149.29

Remed Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															65.30	65.20	65.11	149.29	151.57

Remed Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Remed Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Remed Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Remed Co (XKRX:302550) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Remed Co Ltd (XKRX:302550) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

187 Techno 2-ro, No 301-303, Gwanpyeong-dong, Yuseong-gu, Daejeon, KOR, 34025

Website

http://www.remed.kr

Remed Co Ltd is a Korean medical equipment manufacturing company. The company is engaged in researching and developing products to treat brain disorders such as depression, anxiety, stroke and Parkin's. It has developed TMS device and is manufacturing pain therapy devices using advanced electromagnetic stimulation, shockwave (RSWT) and laser technologies. Its products offerings include Transcranial Magnetic simulator for brain, Electromagnetic simulators including Salus Talent, Salus Talent A, Salus Talent Pro, and Optimus Pro for pain therapy; and Rosetta, Salus RSWT and Optimus Pro as a part of Extracorporeal Shockwave Therapy. It also offers Electrosurgical units from REMED including ELPIS 4L, ELPIS 4, ELPIS 3, and ELPIS2.

Remed Co (XKRX:302550) Headlines

No Headlines